Publications
- Fecal calprotectin is not a clinically useful marker for the prediction of the early nonresponse to exclusive enteral nutrition in pediatric patients with Crohn disease2018 | Second Faculty of Medicine
- Adalimumab versus infliximab in pediatric patients with Crohn's disease: A propensity-score analysis and predictors of treatment escalation2022 | Second Faculty of Medicine
- Is It Useful to Monitor Thiopurine Metabolites in Pediatric Patients with Crohn's Disease on Combination Therapy? A Multicenter Prospective Observational Study2021 | Second Faculty of Medicine, First Faculty of Medicine
- Risk factors for dermatological complications of anti-TNF therapy in a cohort of children with Crohn's disease2021 | Second Faculty of Medicine
- Azathioprine in the therapy of paediatric inflammatory bowel disease - part II: pharmacodynamics, pharmacokinetics, and the possibilities of measuring its metabolites in clinical practice2021 | Second Faculty of Medicine
- Azathioprine in the therapy of paediatric inflammatory bowel disease - part I: treatment indications, dosing and thiopurine-related adverse events2021 | Second Faculty of Medicine
- The Accuracy of a Home-performed Faecal Calprotectin Test in Paediatric Patients With Inflammatory Bowel Disease2019 | Second Faculty of Medicine
- Prediction of Thiopurine Metabolite Levels Based on Haematological and Biochemical Parameters2019 | Second Faculty of Medicine
- Low predictive value of histopathological scoring system for complications development in children with Crohn's disease2017 | Second Faculty of Medicine
Loading network view...